Abstract
To overcome bacterial resistance, more potent antibiotics with broader spectrum of activity were discovered like tigecycline, which is a minocycline derivative. However, the current literature suggests the need for an investigation regarding the occurrence of adverse events with minocycline and tigecycline. This study aimed to explore the frequency of adverse events associated with the use of minocycline and tigecycline from the FDA adverse events reporting system (FAERS) database.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
